All In Biotech

Free tool

FAERS Monitor: Aimovig

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761077 or its brand name (Aimovig, Erenumab-Aooe). Reports on generic versions are filed under their own applications.

Reports

55,567

Serious

12,192

22% of reports

Hospitalization

4,696

Death reported

3,183

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • device difficult to use10,278
  • accidental exposure to product10,273
  • wrong technique in product usage process9,519
  • drug dose omission by device6,743
  • migraine5,427
  • drug ineffective4,511
  • headache3,684
  • constipation3,196
  • product storage error2,980
  • injection site pain2,934
  • off label use2,925
  • nausea2,559
  • fatigue2,422
  • alopecia2,331
  • pain2,098

Reports by year received

View as table
YearReports
20091
20141
20156
20164
201710
20187,441
201911,258
20208,628
20216,012
20225,931
20235,750
20245,180
20253,093
20262,252

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,998,592 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
device difficult to useSignal10,27869.468.1587,059
accidental exposure to productSignal10,27341.841.0370,101
drug dose omission by deviceSignal6,74335.634.7207,792
migraineSignal5,42722.822.2106,925
wrong technique in product usage processSignal9,51918.618.3152,606
product storage errorSignal2,98013.312.832,880
constipationSignal3,1965.65.412,064
alopeciaSignal2,3314.54.46,403
injection site painSignal2,9343.63.55,660
headacheSignal3,6842.22.22,564
drug ineffective4,5111.31.3325
pain2,0981.31.2143
off label use2,9251.31.2169
nausea2,5591.21.2109
fatigue2,4221.21.167

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.